In-Person CME Webcast
0.75 CME/CE Credit
NOT ONE SIZE FITS ALL: Uncovering the Hidden Faces of Pediatric and Adolescent Eating Disorders
In this practical, case-based discussion, we will explore the less “traditional” ways that eating disorders can present in pediatric and adolescent patients. Specifically, we will discuss the diagnosis of ARFID and how to approach treatment for this condition. We will also discuss eating disorder presentation and treatment in male patients and athletes. Finally, we will touch upon the nuances of treating patients with binge eating disorder in this new era of widespread weight loss medication use.
CME/CE Information
0.75 AMA PRA Category 1 Credits or 0.75 AANP, including 0.38 AANP Pharm
Release Date: 10/23/2025
Expiration Date: 12/7/2025
Faculty
Learning Objectives
- Summarize the diagnostic criteria for ARFID, and develop a framework for initial stages of diagnosis and treatment
- Describe the unique challenges that male adolescents with eating disorders face, and develop strategies to address these challenges in the primary care setting
- Outline the diagnostic criteria for REDs, and develop strategies to counsel adolescent athletes about this condition
- Discuss the nuances of treating patients in larger bodies who have eating disorders
Faculty
Anne Powell, MD
Chief, Division of Adolescent Medicine, Assistant Professor of Pediatrics, UMass Memorial Children's Medical Center
Learn MoreDisclosures
All individuals in control of content for this activity (including faculty, moderator, editors, reviewers) have disclosed no relevant financial relationships.
CME/CE Information
AMA PRA Category 1 Credits
Accreditation Statement
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP
Accreditation Statement
Pri-Med Institute is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 040308.
Designation Statement
This activity is approved for 0.75 contact hour, which includes 0.375 hour of pharmacology.
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.